LA HB403 | 2024 | Regular Session

Status

Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Passed on May 15 2024 - 100% progression
Action: 2024-05-15 - Effective date: 07/01/2024.
Text: Latest bill text (Chaptered) [PDF]

Summary

Adds drugs prescribed for certain ocular conditions to the listing of prescription drugs exempt from local sales and use taxes (EN DECREASE LF RV See Note)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Adds drugs prescribed for certain ocular conditions to the listing of prescription drugs exempt from local sales and use taxes (EN DECREASE LF RV See Note)

Sponsors


Roll Calls

2024-05-07 - Senate - Senate Vote on HB 403 FINAL PASSAGE (#553) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2024-03-20 - House - House Vote on HB 403 FINAL PASSAGE (#52) (Y: 104 N: 0 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2024-05-15HouseEffective date: 07/01/2024.
2024-05-15HouseSigned by the Governor. Becomes Act No. 76.
2024-05-09HouseSent to the Governor for executive approval.
2024-05-08SenateSigned by the President of the Senate.
2024-05-08HouseEnrolled and signed by the Speaker of the House.
2024-05-07HouseReceived from the Senate without amendments.
2024-05-07SenateRules suspended. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
2024-04-24SenateReported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
2024-04-23SenateRead by title and referred to the Legislative Bureau.
2024-04-22SenateReported favorably.
2024-03-25SenateRead second time by title and referred to the Committee on Revenue and Fiscal Affairs.
2024-03-20SenateReceived in the Senate. Rules suspended. Read first time by title and placed on the Calendar for a second reading.
2024-03-20HouseRead third time by title, roll called on final passage, yeas 104, nays 0. Finally passed, title adopted, ordered to the Senate.
2024-03-19HouseScheduled for floor debate on 03/20/2024.
2024-03-19HouseRead by title, ordered engrossed, passed to 3rd reading.
2024-03-18HouseReported favorably (16-0).
2024-03-11HouseRead by title, under the rules, referred to the Committee on Ways and Means.
2024-02-29HouseUnder the rules, provisionally referred to the Committee on Ways and Means.
2024-02-29HousePrefiled.

Subjects


Louisiana State Sources

TypeSource
Summaryhttps://www.legis.la.gov/legis/BillInfo.aspx?s=24rs&b=HB403&sbi=y
Texthttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1350663
Texthttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1355091
Texthttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1372571
Texthttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1375969
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1350674
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1353189
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1355271
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1355380
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1372857
Supplementhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1385737
Roll Callhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1356313
Roll Callhttps://www.legis.la.gov/Legis/ViewDocument.aspx?d=1372409

Bill Comments

feedback